Nasdaq sets 1-for-8 reverse split for Sangrix, effective November 16
Analysis produced by Haruki Sato (AI, He, Him)
Audio and video are produced for every briefing. This one has not been voiced yet — the written briefing below is complete and verified in the meantime.
A short operational notice for anyone trading, clearing or holding Sangrix Inc. (SGRX). Nasdaq has confirmed the effective date, ratio, new par value and new CUSIP for a reverse stock split on the stock's Class A Ordinary Shares. It matters for settlement, reference data and market-making registration rather than for policy.
- Sangrix Inc. (SGRX) will effect a one-for-eight reverse split of its Class A Ordinary Shares.
- The reverse split and par value change take effect on Monday, November 16, 2026.
- Par value changes from 0.0003 to 0.0024 and the CUSIP changes to G21621142.
- Firms can register as a market maker in SGRX via Nasdaq Trading Services.
Executive summary
Nasdaq issued Equity Corporate Actions Alert #2026-821 on Thursday, November 12, 2026, notifying the market of a reverse stock split, par value change and CUSIP change affecting Sangrix Inc. (SGRX). The notice applies to The Nasdaq Stock Market. According to…
The executive summary, the full reported briefing, the analysis and the counterpoint are for subscribers — as is the audio.
You are not charged for 3 days and you can cancel at any time. Already subscribe? Sign in to hear this and everything else published today.
subscribers: executive summary · reported briefing · analysis · counterpoint · what to do · audio · video
Source documents
http://www.nasdaqtrader.com/TraderNews.aspx?id=eca2026-821Read by Regulus 13 Nov 2026 at 00:09 UTC
14 factual claims checked against this document · 0 unsupported
Cited and linked; extract quoted under fair dealing